Vancouver, British Columbia--(Newsfile Corp. - March 3, 2017) - Alliance Growers Corp. (CSE: ACG) (FWB: 1LA) (WKN: A2DFYX) ("Alliance Growers" or the "Company") announces that the Company has executed on the term sheet for a financing commitment offered by
a U.S. based private equity firm for a $5 Million equity facility in a series of private placements with an option to go to $10
million. This arrangement was previously referenced in a news release on February 14, 2017.
The purpose of the Equity Facility is to provide the Company with financial flexibility and control over the financial
requirements for its many exciting and integrated projects, providing access to capital as deemed necessary by the Company.
In the past two years, this U.S. based private equity firm has offered and signed definitive agreements with other strong
companies in the cannabis sector. The firm approached Alliance with a similar arrangement based on their belief in the Alliance
Growers' 'Four Pillars' business strategy. Incredible opportunity exists in the cannabis and cannabis-related sectors and there are
few teams in the industry that can fully avail themselves of all that opportunity without adequate funding. The industry is rapidly
changing and evolving and companies need to position themselves for where the industry is going, like Alliance has done. Part of
that positioning for Alliance consists of its strategy to add value to every Licensed Producer individually, like Canwe and for the
entire industry as a whole, and to quickly evolve to utility-like levels of reliability, consistency of product or experience, and
stringent high standards of quality control.
"We are very excited to have received the strong vote of confidence from this notable financial equity firm. The fact that they
share our view of where the cannabis market is going is a significant endorsement of Alliance Growers longer term business
strategy. This offer of financing will provide the Company with the financial flexibility to ensure that it can execute on its
business plan. We look forward to updating investors on our progress, " said Dennis Petke, Alliance Growers' President and CEO.
About Alliance Growers
Alliance Growers Corp is a diversified cannabis company driven by the Company's 'Four Pillars' Organization Plan — Cannabis
Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.
Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License
to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany
lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in
general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation,
specifically the "Chibafreen Invitro Plant Production System", which assures consistent composition and purity of each plantlet for
the growers.
Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain
proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer
Applicants at various stages in the Health Canada License process.
For further information, please visit the Company's corporate website at www.alliancegrowers.com or the Company's profile at www.sedar.com.
If you would like to be added to Alliance Growers' news distribution list, please send your email address
to newsletter@alliancegrowers.com
On behalf of the board of directors of
ALLIANCE GROWERS CORP.
"Dennis Petke"
Dennis Petke
President and CEO
For more information contact:
Dennis Petke
Tel: 778-331-4266
DennisPetke@alliancegrowers.com
Rob Grace
Corporate Communications Consultant
Tel: 778-998-5431
RobGrace@alliancegrowers.com
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY
OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable
securities laws. These statements relate to future events or future performance. All statements other than statements of historical
fact may be forward-looking statements or information. More particularly and without limitation, the news release contains
forward-looking statements and information relating to Company's corporate strategy. The forward-looking statements and information
are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the
Company's ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions
on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the
forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current
expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements
and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements
and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results
could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited
to, the Company's ability to identify and complete additional suitable acquisitions to further the Company's growth as well as
risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or
changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the
uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing
and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market;
ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals
and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place
undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned
that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no
undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new
information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The
forward-looking statements or information contained in this news release are expressly qualified by this cautionary
statement.
